RxDoctor Payments Data

Betti Reese, MD

Family Medicine · Greensboro, NCNPI 1922063114

Payments from drug & device makers

$2,911in general payments, 2019–2025

Across 174 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$455
  • Novo Nordisk$369
  • Pfizer$293
  • AbbVie$268
  • Amgen$243
  • AstraZeneca$188
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,911100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,911 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,695
Medicare patients
51
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide122$144,312
FarxigaDapagliflozin Propanediol66$65,352
MounjaroTirzepatide25$35,186
JardianceEmpagliflozin33$19,443
EliquisApixaban22$11,450
Tresiba Flextouch U-100Insulin Degludec12$8,047
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen155$6,783
SymbicortBudesonide/Formoterol Fumarate15$6,263
LinzessLinaclotide11$5,865
Sumatriptan16$4,709
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,758
Novolog FlexpenInsulin Aspart21$2,183
Tramadol Hcl46$1,999
Albuterol Sulfate HfaAlbuterol Sulfate61$1,897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$369$144,312122 claims
AstraZenecaFarxiga, Symbicort$188$71,61581 claims
Lilly USA, LLCMounjaro$455$35,18625 claims
PfizerEliquis$293$11,45022 claims
AbbVieLinzess$268$5,86511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →